Pozostałe działy:

BIOINFO Pharmaceutical Biotechnology

Bioinfo Publications

BIOINFO Pharmaceutical Biotechnology, ISSN: 2249–1813 & E-ISSN: 2249–1821, a broad-based journal was founded on two key tenets: To publish the most exciting researches with respect to the subjects of Pharmaceutical Biotechnology. Secondly, to provide a rapid turn-around time possible for reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.

BIOINFO Pharmaceutical Biotechnology-open access gives a worldwide access larger than that of any subscription-based journal in field, no matter how prestigious or popular, and probably increases the visibility and impact of published work. BIOINFO Pharmaceutical Biotechnology -open access gives barrier-free access to the articles for research. It increases convenience, reach, and retrieval power. Free online articles is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. BIOINFO Pharmaceutical Biotechnology - Open access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content.

All published articles will be available online and will keep upto date with latest advances in the field and papers published in Bioinfo Publications will reach the readers directly by email for free of cost.

Distributed world widely through the Internet.

Archived online in the transactions of the Bioinfo Publications, which provides the international scientific community with immediate and permanent access to individual papers.

BIOINFO Pharmaceutical Biotechnology accepts online letters to the editors, brief comments that contribute to the previously published articles or other relevant finding in field.

Open Access is a publication model that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under open access can be accessed by anyone with internet connection. BIOINFO Pharmaceutical Biotechnology  strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by BIOINFO Pharmaceutical Biotechnology are freely accessible to everyone immediately after publication.